Sec Form 13D Filing - AINOS INC filing for - 2026-04-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D



Comment for Type of Reporting Person:
The number of securities in Row 7 includes (i) 491,263 shares of common stock, $0.01 par value, of Ainos, Inc., a Texas corporation (the "Issuer"), owned directly by Ainos Inc., a Cayman Islands company ("Ainos KY"), (ii) 3,649,158 shares pursuant to a Voting Agreement dated January 1, 2026 (the "2026 Voting Agreement"), by and among the Reporting Person, and Chun-Hsien Tsai, Ting Chuan Lee, Chun-Jung Tsai, Chung-Yi Tsai, Chih-Heng Lu, Taiwan Carbon Nano Technology Corporation ("TCNT"), and Hsin-Liang Lee, and (iii) 667,085 shares pursuant to a Voting Agreement dated May 3, 2024 between Ainos KY and ASE Test, Inc. ("ASE Test" and the "ASE Voting Agreement," together with the 2026 Voting Agreement, the "Voting Agreements") (with the 667,085 ASE Test shares consisting of the following (a) 11,777 shares owned by ASE Test, (b) 105,868 shares issuable to ASE Test upon conversion of outstanding convertible notes of the Issuer (c) 449,440 shares issuable to ASE Test upon conversion of a convertible note of the Issuer issuable within 60 days), and (d) 100,000 shares issuable to ASE Test upon exercise of warrants to purchase 100,000 shares of the Issuer with ASE Test). The numbers in Rows 9, 11 and 13 represents beneficial ownership of 491,263 shares of common stock of the Issuer, consisting of 491,263 shares owned directly by Ainos KY and excludes 4,316,243 shares pursuant to the Voting Agreements. The percentage in Row 13 is based on the sum of, (i) 7,266,011 shares of Common Stock outstanding as of March 30, 2026 as set forth in the Annual Report on Form 10-K of the Issuer filed with the SEC on March 30, 2026, (ii) 19,531 shares issued for service fee on April 1, 2026; and (iii) 1,239,000 shares of Common Stock granted and vested on April 15, 2026 under the Ainos, Inc. 2023 Stock Incentive Plan.


SCHEDULE 13D

 
AINOS INC
 
Signature:/s/ Chun-Hsien Tsai
Name/Title:Chun-Hsien Tsai/Director and CEO
Date:04/17/2026
primary_doc.xml